FDA Inspection 1103189 - Takeda Pharmaceutical Company Limited - September 25, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Takeda Pharmaceutical Company Limited

Record Details

This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on September 25, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Takeda Pharmaceutical Company Limited
Inspection Date: September 25, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · f815b5da-2d6a-4e03-8688-006a8fbebf36

Violation Codes3

21 CFR 123.8(a)(3)(ii)21 CFR 640.81(c)21 CFR 807.22(a)

Full citation text and observation details available on the Dashboard.